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Introduction.Penilecarcinomahastraditionallybeentreatedbyeithersurgicalamputationorradicalradiotherapy,bothassociated
withdevastatinganatomical,functional,andpsychologicalimpactonthepatient’slife.Innovativesurgicaltechniqueshavefocused
on penile preservation in well-selected patients to minimize physical disﬁgurement and consequently maximize quality of life. The
objectiveofthisarticleistodeﬁnethecurrentstatusoftheseorgan-preservingsurgicaloptionsforpenilecarcinoma.Materials and
Methods. An extensive review of the Pubmed literature was performed to ﬁnd articles discussing only reconstructive surgery which
have contributed signiﬁcantly to change traditional, frequently mutilating treatments, to develop less disﬁguring surgery, and to
improve patients’ quality of life over the last two decades. Results. Several articles were included in this analysis in which a major
contribution to the change in therapy was thought to have occurred and was documented as beneﬁcial. Some articles reported
novel techniques of less-mutilating surgery involving diﬀerent forms of glans reconstruction with the use of ﬂaps or grafts. The
issue of safe surgical margins was also addressed. Conclusion. The development of less-disﬁguring techniques allowing phallus
preservation has reduced the negative impact on functional and cosmetic outcomes of amputation without sacriﬁcing oncological
objectives in appropriately selected patients based on stage, grade, and location of the tumour. Until more prospective studies are
available and solid evidence is documented, organ preservation should be oﬀered with caution.
Copyright © 2008 Francisco E. Martins et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
In the industrialized world, particularly in Europe and in the
USA, penile carcinoma is an uncommon malignancy with
an incidence of less than 1 per 100000 of the male adult
population. However, its incidence may be as high as 19 per
100000 in parts of Asia, South America, Africa and may even
reach50per100000malesinpartsofnorth-easternBrazilian
states[1,2].Thisdiﬀerentworldwidedistributionvarieswith
age, circumcision, and hygiene patterns.
Historically, the majority (90%) are primary carcinomas,
of which 95% are squamous cell carcinomas, involving the
glans, prepuce, or both in over 78% of the cases. The
management of penile carcinoma, particularly its invasive
form, has changed little over the decades. Available treat-
ments include surgical amputation and penis-preserving
treatments, either surgical (circumcision, laser ablation,
Mohs micrographic surgery, glansectomy associated with
various forms of reconstruction) or nonsurgical (radiother-
apy, immunotherapy, chemotherapy). Surgical amputation
is the oldest of all modalities [3] .I th a sr e s u l t e di nl o c a l
control rates greater than 90% of the primary tumor and,
therefore, remains the oncological “gold standard” for all
stages[4–6].Althoughtheradicalsurgicalapproachprovides
excellent local control, it is often mutilating and is associated
with urinary and sexual dysfunction as well as dramatic
psychological morbidity [7]. These negative factors have led
to a signiﬁcant change in the approach to the primary penile
lesion and to the development of several surgical organ-
preserving techniques. Nowadays, the deﬁnitive treatment
of penile carcinoma is stage-dependent, with the penile-
preservingoptionsespeciallyreservedforlow-gradeandlow-
stage tumors. These techniques aim to remove as little of
the functional anatomy as possible, without compromising
local oncological radicality [8]. However, data from retro-
spective studies suggest a statistically higher local recurrence2 Advances in Urology
rate following penis-preserving treatments compared with
radical surgery. Most recurrences are surgically salvageable
and overall mortality is comparable to primary amputation
[9]. The objective of this article is to give an overview of the
current status and the role of these organ-preserving surgical
options for penile carcinoma and state their limitations.
2. INDICATIONS AND GOALS OF
ORGAN PRESERVATION
Some retrospective studies have reported good cosmetic and
functional outcomes with conservative treatment options
and an overall organ preservation of 60% [9]. Because about
80% of penile carcinomas occur distally, involving the glans
and/or prepuce, they are potentially amenable to organ-
preserving surgery [10, 11].
It is generally accepted that patients with penile carcino-
mas associated with favourable histology (stages Tis, Ta, T1;
grades 1 and 2) are at low risk for local progression and/or
distant metastatic spread (Table 1). These patients are also
the best candidates for penile-/glans-preserving treatment
options [2] .R e c e n t l y ,h o w e v e r ,s o m es e r i e sh a v es u g g e s t e d
that these indications can be expanded in order to include
T 2a n de v e ns o m ed i s t a lT 3t u m o r sa sw e l la sr e c u r r e n c e s
after radiotherapy [8]. Nonetheless, until more rigorous
scientiﬁc evidence is available, organ-preserving strategies
shouldbereservedtowell-selectedpatientswithlimitedlow-
grade, low-stage disease [11, 12]. A traditional 2cm excision
margin has been challenged as unnecessary for patients
undergoing partial penectomy for squamous cell carcinoma.
Conservative techniques involving surgical margins of only
less than 10mm appear to oﬀer excellent oncological control
[13, 14].
Thegoalsofpenile-preservingtreatmentsaretomaintain
penile/glans sensation and to maximize penile shaft length
where possible. However, cosmetic and functional results
should not compromise long-term oncological outcomes.
3. METHODS OF SURGICAL ABLATION FOR
ORGAN PRESERVATION
A variety of penile-preserving therapeutic approaches have
been used for low-grade and low-stage penile carcinoma,
including topical treatments (5-ﬂuorouracil or imiquimod
cream for Tis only), radiotherapy, Mohs micrographic
surgery, laser ablation or excision, and conservative excision
strategies (Table 2). This article will focus exclusively on
surgicalstrategiestoachieveorganpreservation.Nonsurgical
options are beyond the scope of this review.
3.1. Mohsmicrographicsurgery
Mohs micrographic surgery (MMS) refers to a surgical
technique of excising accessible tumors under microscopic
control [15]. The tumor is excised in layers and the
undersurface of each layer is examined microscopically by
systematic frozen sections in multiple sessions. This excision
is continued until the undersurface of the excised tissue
is negative, at which point another section of tissue is
Table 1: TNM classiﬁcation of penile carcinoma (1997/2002).
T-Primary tumor
TX Primary tumor cannot be assessed
T0 No evidence of primary tumor
Tis Carcinoma in situ
Ta Non-invasive verrucous carcinoma
T1 Tumor invades subepithelial connective tissue
T2 Tumor invades corpus spongiosum or cavernosum
T3 Tumor invades urethra or prostate
T4 Tumor invades other adjacent structures
N-Regional lymph nodes
NX Regional lymph nodes cannot be assessed
N0 No evidence of lymph node metastasis
N1 Metastasis in a single inguinal lymph node
N2 Metastasis in multiple or bilateral superﬁcial lymph nodes
N3 Metastasis in deep inguinal or pelvic lymph nodes, unilateral or
bilateral
M-Distant metastasis
MX Distant metastases cannot be assessed
M0 No evidence of distant metastases
M1 Distant metastases
removed to ensure a clear resection margin. This sequential
microscopic guidance oﬀers increased precision and control
of the negative surgical margin, while maximizing safe organ
preservation. MMS is most commonly used for skin tumors
but the accessibility of penile carcinomas (most commonly
on the glans) makes it a suitable candidate for such a
procedure. In Mohs’ 50-year experience with 35 cases, the
success rate was stage-dependent. A percentage of 86%
of stage T1 and 82% of stage T2 cases were tumor-free
compared to none of stage T3 at a followup of 5 years.
This technique is attractive because it allows reassurance
of local complete excision and preservation of local penile
anatomy and function. However, because local failure rate
is apparently higher (32%) than amputation, it should be
reserved to patients with penile carcinoma in situ or with
small, distal, superﬁcially invasive tumors. Further reports
with this technique are necessary to allow comparison and
reproducibility of outcomes in order to encourage its more
widespread use. Complications may include meatal stenosis
and glans disﬁgurement.
3.2. Laserablationorexcision
Penile laser surgery has been used since the 1980s. The four
t y p e so fl a s e r su s e da r ec a r b o nd i o x i d e ,a r g o n ,n e o d y m i u m
yttrium aluminium garnet (Nd:YAG), and potassium titanyl
phosphate (KTP) lasers, the CO2 and Nd:YAG modes
being the most commonly used in current practice [16, 17].
CO2 laser has a very low penetration power (only 0.1mm)
and is, therefore, unsuitable for most tumors, resulting in
r e c u r r e n c er a t e so fu pt o5 0 %[ 18]. Nd:YAG has a muchFrancisco E. Martins et al. 3
Table 2: Organ-preserving therapeutic strategies for penile carcinoma.
A nonsurgical
(1) Topical treatments
5-Fluoroacil solution
Imiquimol cream
(2) Radiotherapy
Plesiotherapy
Interstitial brachytherapy
External beam radiotherapy
(3) Cryosurgery
(4) Chemotherapy
(5) Immunotherapy
B Surgical
(1) Laser ablation or
excision
CO2
Nd:YAG
KTP
(2) Mohs micrographic
surgery
Circumcision
(3) Conservative surgery
Glans-preserving
techniques Partial glansectomy
with primary closure
with graft reconstruction of
the glans
Split-thickness skin grafts
Full-thickness skin grafts
Buccal mucosa
Glans-removing
techniques Total Glansectomy
with split-thickness skin
grafts
with distal corporectomy
and reconstruction
higher penetration power of about 6mm due to its rather
short wavelength (λ = 1.06μm, i.e., 10 times less than CO2),
resulting in protein denaturation at such depth. Overall
recurrence rates after laser ablation are also stage-dependent,
averaging 7.7% for Tis tumors, and as high as 25% for T1
lesions [16]. Other authors have reported good outcomes
afterNd:YAGlaserforT1tumorswithexcellentcosmeticand
functional results and high satisfaction rates. Recurrences
were noted in 6.9% of the patients, which is comparable to
recurrence rates after partial amputation (0–8%) [19].
The available data to date demonstrate that laser surgery
is feasible and may achieve results comparable to those of
traditionalamputativesurgery,particularlyinhighlyselected
patients and in conjunction with frozen-section biopsies.
Additionally, it has signiﬁcant anatomical, cosmetic, and
functionaladvantagesovertraditionalamputation.However,
as the local recurrence is higher, a close surveillance is
mandatory for early detection. Therefore, patient selection
is extremely important. Because in laser surgery the depth of
tumorinvasioniscrucial,onlythoseinvadinglessthan6mm
into tissues are suitable for this treatment modality.
3.3. Conservativesurgery
Circumcision
It is the most simple and common surgical procedure in
the management of penile carcinoma. The majority of men
with penile carcinoma are uncircumcised. It is indicated for
symptomatic treatment of painful or haemorrhagic tumors
as well as for acquired phimosis secondary to preputial
tumors. It is always recommended before radiotherapy as it
allows better targeting and deﬁnition of the tumor, simul-
taneously preventing preputial radiotherapy-related adverse
reactions, and, above all, it improves local oncological
surveillance. Noteworthy, circumcision alone is a suﬃcient
primary curative treatment for small low-stage (Tis, Ta, T1)
and low-grade (grades 1 and 2) disease limited to the distal
prepuce [20] .I ft h et u m o ri sm o r ep r o x i m a la n dc l o s et o
the coronal sulcus, the circumcision margin will need to be
extended proximally to the penile shaft to ensure adequate
o n c o l o g i c a lr e s e c t i o n ,a sr e c u r r e n c er a t e sm a yb ea sh i g ha s
50% [21]. Therefore, case selection is critical to reduce local
recurrence rates.
Glansectomy
It can be done either partial or total, has recently been
introduced for the local excision of distal tumors on the
glans and prepuce [8, 12, 22, 23]. Frozen sections from the
cavernosal bed and urethral stump should be carried out
during the procedure to ensure negative surgical margins
followed by an end-shaft urethrostomy. Glansectomy is usu-
ally combined with grafting procedures to create a neoglans.
Basically, there are 2 forms of glansectomy: (i) partial
glansectomy, which removes the portion of the glans aﬀected4 Advances in Urology
(a) Superﬁcial glans carcinoma (b) outer preputial ﬂap outlined
(c) glans lesion has been excised and circumcision
performed
(d) surgical glans defect covered by preputial ﬂap
Figure 1: Outer preputial full-thickness skin ﬂap as described by Ubrig et al. (2001) to cover surgical glans defects.
by the tumor, leaving behind remaining glanular epithelium
with malignant potential, and (ii) total glansectomy, which
removes all the glans tissue, thus preventing ‘de novo’ tumor
growth.
Traditionally, amputative surgery has been based on
the assumption that a 2cm resection margin is required
to achieve local oncological clearance [24]. However, the
scientiﬁc value of a 2cm margin has not been supported
uniformly and several authors have recently questioned it
[13, 14, 25], concluding in their studies that a 2cm surgical
margin was not only unnecessary but also overtreatment
in many cases. About 80% of the penile carcinomas arise
distally, which render them potential candidates for penile-
preserving surgery. This type of surgery includes an extir-
pative component leaving in some cases a simple defect
amenable to primary closure. If the defect is larger and
primary closure is not possible or safe, various techniques
have been suggested to cover or reconstruct the area [8,
12, 22, 23, 26–33]. Ubrig described a simple technique in
2001 in which an outer preputial skin ﬂap was used to
cover the glans defect if primary closure was impossible.
However, the tumor should not be too deep (Figure 1).
Pietrzaketal.havesuggestedtheuseofafull-thicknessﬂapof
penile skin or extragenital (lateral aspect of the thigh) split-
thickness skin graft to reconstruct the glans associated with
partial or total glans removal. In cases of invasion of tunica
albugineabydistaltumors,distalcorporectomywasincluded
[8].Inglans-preservingprocedures,partialglansectomywith
primary glans closure was essentially an excisional biopsy
of a small distal tumor. Larger lesions necessitated partial
glansectomy followed by glans reconstruction which was
performed with the use of split-thickness or full-thickness
grafting. In glans-removing procedures, total glansectomy
was performed followed by either split-thickness skin graft
reconstruction or reconstruction of cavernosal tips and
grafting, if a distal corporectomy was required. In some
cases, a penile-lengthening procedure was added to the
reconstruction to maintain as much cavernosal tissue as
possible. In all forms of penile-preserving surgery, a frozen
biopsy of the surgical bed is mandatory to conﬁrm tumor
clearance (negative margins). A subtotal glans excision with-
out grafting has been described as a simple and cosmetically
attractive alternative to other forms of conservative surgery
for penile carcinoma [23]. This procedure involves excision
of the tumor and glans between 2 incision lines leaving the
urethra intact. The residual glans and urethral meatus is
sutured down to the distal corpora and the penile skin is
advanced to be sutured to the distal glans at the level of
spatulated urethra. A urethral catheter is left indwelling for
24 hours. No skin or any other source of grafting is required
and the patient is discharged the next day. Apparently,
patients maintain their voiding characteristics unchanged
(e.g., no spraying) and avoid graft-related complications
(e.g., donor-site morbidity, graft failure, and infection).
However, this technique should be avoided in patients with
penile tumors very close to (less than 5mm) or invading
the urethral meatus. Other forms of glansectomy without
glans reconstruction have also been described [22, 33].
These usually create a new urethral stoma and attach the
residual urethra to the foreskin with acceptable cosmetic
and functional outcomes. However, some authors have
reportedthattheseproceduresonlypartiallyresolveaesthetic
and psychological problems associated with surgery. Also,
they do not resolve the question of penile sensation, and
consequentlyejaculationandorgasm,aswellaspenilelength
and appearance. To overcome these pitfalls, they suggested
a technique of glans reconstruction using the distal urethra
[27].Francisco E. Martins et al. 5
(a) Glans tumor (b) Total disassembly of the penis (c) Glans is completely dissected
from the corpora cavernosa
(d) Glans removal and urethral
spatulation for glans reconstruction
(e) Glans has been reconstructed
and urethra sutured to the corporal
tips
(f) Appearance at the end of the
surgery
(g) Appearance at 6 months after surgery
Figure 2: Penile disassembly for the conservative treatment of penile carcinoma.
More recently, an alternative approach to organ-sparing
surgery for penile carcinoma based on a penile disassembly
technique has been utilized by Djordjevic et al. with good
results [28]. Penile disassembly was ﬁrst described by Perovic
in the early 1990s as a surgical technique to treat most
congenital and acquired penile deformities in paediatric
and adult male populations, such as hypospadias, extrophy-
epispadias complex, penile curvature, and Peyronie’s dis-
ease. This technique has been employed in low-grade and
low-stage tumors, mostly T1G1-2 lesions. The procedure
begins with urethral mobilization together with Bucks fascia
(Figure 2). Dorsally, the neurovascular bundle is dissected
oﬀ by blunt and sharp manoeuvres. Glans with urethra
ventrally and neurovascular bundle dorsally are completely
separated from the corpora cavernosa. The neurovascular
bundle is divided 2cm proximal tothe glans cap. The glans is
removed after division of the urethra. Biopsies of the surgical
margins are performed routinely to conﬁrm oncological
clearance. The urethra is spatulated 4cm in length and
sutured to the corpora cavernosa. The spatulated urethra
is used for neoglans construction. The corpora cavernosa
are ﬁxed to the skin proximally using U-shaped sutures to
avoid penile retraction. Reconstruction of the penile skin is
performedasincircumcision.Theauthorsbelievethatpenile
disassembly represents a radical but very useful approach to
organ-preserving surgery in penile carcinoma with excellent
cosmetic, functional, and oncological outcomes.
Some authors have long reported on a surgical strategy
for refashioning of phallus stumps to make them longer and
more natural in appearance. Where this was not feasible,
a neophallus was performed. Perineal urethrostomy was
avoided completely [29, 33]. This was even considered to
reﬂect a failure of surgical skill [29].
Total glansectomy for penile tumors was ﬁrst described
by Austoni in 1996 [34]. Since that time, enormous eﬀorts
have been made in the development of more reﬁned and6 Advances in Urology
appealing surgical alternatives to improve both function and
cosmesis, as well as local oncological control. Early results
have been encouraging but more reproducible studies and
longer followup are still required to consider organ preser-
vation as the gold standard treatment of penile carcinoma.
Until then, it should be used with caution.
4. CONCLUSION
Historically, amputative surgery and radical radiotherapy
were the only options to treat penile carcinoma. Over
the last two decades, several innovative techniques have
been described and proposed for organ-preserving surgery
in penile carcinoma. These should avoid complications
and maximize both cosmetic and functional outcomes,
simultaneously not compromising local oncological long-
term control. At present, deﬁnitive management of penile
carcinoma remains stage-dependent. Penile amputation has
been challenged by more recent conservative surgical tech-
niques and should perhaps be considered overtreatment in
low-stage disease. Glansectomy appears to oﬀer good local
control rates. Glans reconstruction with or without grafting
procedures have oﬀered excellent cosmetic results where
applicable. However, until further studies are available and
suﬃcient evidence reproducible in common day practice,
and until the surgical margin issue is safely addressed in
prospective studies, penile amputation (partial or total)
with all its attendant anatomical, psychosocial, and sexual
disabilities should still be regarded as the gold standard
treatment for all stages of penile carcinoma, even for Tis, Ta
and T1 tumors.
REFERENCES
[ 1 ]F .R .R o m e r o ,K .R .R o m e r o ,M .A .M a t t o s ,C .R .G a r c i a ,R .
C. Fernandes, and M. D. Perez, “Sexual function after partial
penectomyforpenilecancer,”Urology,vol.66,no.6,pp.1292–
1295, 2005.
[2] E. F. Solsona, S. Algaba, G. Horenblas, G. Pizzocaro, and
T. Windahl, “EAU guidelines on penile cancer,” European
Urology, vol. 46, no. 1, pp. 1–8, 2004.
[3] L. Lewis, “Young’s radical operation for the cure of cancer of
the penis: a report of 34 cases,” The Journal of Urology, vol. 26,
p. 295, 1931.
[ 4 ]W .S .M c D o u g a l ,F. K .K i r s c h n e rJ r . ,R .H .E d w a r d s ,a n dL .
T. Killion, “Treatment of carcinoma of the penis: the case for
primary lymphadenectomy,” The Journal of Urology, vol. 136,
no. 1, pp. 38–41, 1986.
[ 5 ] S .H o r e n b l a s ,H .v a nT i n t e r e n ,J .F .M .D e l e m a r r e ,T .A .B o o n ,
L. M. Moonen, and V. Lustig, “Squamous cell carcinoma of
the penis. II. Treatment of the primary tumor,” The Journal of
Urology, vol. 147, no. 6, pp. 1533–1538, 1992.
[6] G. Pizzocaro, L. Piva, G. Bandieramonte, and S. Tana, “Up-
to-date management of carcinoma of the penis,” European
Urology, vol. 32, no. 1, pp. 5–15, 1997.
[7] S. Opjordsmoen and S. D. Fossa, “Quality of life in patients
treated for penile cancer. A follow-up study,” British Journal of
Urology, vol. 74, no. 5, pp. 652–657, 1994.
[8] P. Pietrzak, C. Corbishley, and N. Watkin, “Organ-sparing
surgery for invasive penile cancer: early follow-up data,” BJU
International, vol. 94, no. 9, pp. 1253–1257, 2004.
[9] D. Cotsadze, B. Matveev, B. Zak, and V. Mamaladze, “Is
conservative organ-sparing treatment of penile carcinoma
justiﬁed?” European Urology, vol. 38, no. 3, pp. 306–312, 2000.
[10] R. Sarin, A. R. Norman, G. G. Steel, and A. Horwich,
“Treatment results and prognostic factors in 101 men treated
for squamous carcinoma of the penis,” InternationalJournalof
Radiation Oncology, Biology, Physics, vol. 38, no. 4, pp. 713–
722, 1997.
[11] N. K. Bissada, H. H. Yakout, W. E. Fahmy, et al., “Multi-
institutional long-term experience with conservative surgery
forinvasivepenilecarcinoma,”TheJournalofUrology,vol.169,
no. 2, pp. 500–502, 2003.
[12] J. W. Davis, P. F. Schellhammer, and S. M. Schlossberg, “Con-
servative surgical therapy for penile and urethral carcinoma,”
Urology, vol. 53, no. 2, pp. 386–392, 1999.
[13] A. Agarwal, D. Pai, N. Ananthakrishnan, S. R. Smile, and
C. Ratnakar, “The histological extent of the local spread of
carcinoma of the penis and its therapeutic implications,” BJU
International, vol. 85, no. 3, pp. 299–301, 2000.
[14] S. Minhas, O. Kayes, P. Hegarty, P. Kumer, A. Freeman,
and D. Ralph, “What surgical resection margins are required
to achieve oncological control in men with primary penile
cancer?”BJUInternational,vol.96,no.7,pp.1040–1043,2005.
[15] F. E. Mohs, S. N. Snow, and P. O. Larson, “Mohs micrographic
surgery for penile tumors,” The Urologic Clinics of North
America, vol. 19, no. 2, pp. 291–304, 1992.
[16] T. R. Malloy, A. J. Wein, and V. L. Carpiniello, “Carcinoma of
penistreatedwithneodymiumYAGlaser,”Urology,vol.31,no.
1, pp. 26–29, 1988.
[17] A. C. von Eschenbach, D. E. Johnson, K. I. Wishnow, R.
J. Babaian, and D. Tennay, “Results of laser therapy for
carcinoma of the penis: organ preservation,” Progress in
Clinical and Biological Research, vol. 370, pp. 407–412, 1991.
[18] B. P. J. van Bezooijen, S. Horenblas, W. Meinhardt, and D. W.
W.Newling,“Lasertherapyforcarcinomainsituofthepenis,”
The Journal of Urology, vol. 166, no. 5, pp. 1670–1671, 2001.
[19] D. Frimberger, E. Hungerhuber, D. Zaak, R. Waidelich, A.
Hofstetter, and P. Schneede, “Penile carcinoma. Is Nd:YAG
lasertherapyradicalenough?”TheJournalofUrology,vol.168,
no. 6, pp. 2418–2421, 2002.
[20] N.K.Bissada,“Conservativeextirpativetreatmentofcancerof
the penis,” The Urologic Clinics of North America, vol. 19, no.
2, pp. 283–290, 1992.
[21] A.S.Narayama,L.E.Ohney,S.A.Loening,G.W.Weimar,and
D. A. Culp, “Carcinoma of the penis: analysis of 219 cases,”
Cancer, vol. 49, no. 10, pp. 2185–2191, 1982.
[22] D. G. Hatzichristou, A. Apostolidis, V. Tzortzis, K. Hatz-
imouratidis, E. Ioanmides, and K. Yannakoyorgos, “Glan-
sectomy: an alternative surgical treatment for Buschke-
L¨ owenstein tumors of the penis,” Urology,v o l .5 7 ,n o .5 ,p p .
966–999, 2001.
[23] C.T.Brown,S.Minhas,andD.J.Ralph,“Conservativesurgery
for penile cancer: subtotal glans excision without grafting,”
BJU International, vol. 96, no. 6, pp. 911–912, 2005.
[24] P. F. Schellhammer, G. H. Jordan, and S. M. Schlossberg,
“Tumors of the penis,” in Campbell’s Urology,P .C .W a l s h ,A .
B. Retik, T. A. Stamey, and E. D. Vaughn, Eds., vol. II, chapter
31 of , pp. 1264–1298, WB Saunders, Philadelphia, Pa, USA,
6th edition, 1992.
[25] M. Hoﬀman, A. Renshwa, K. Loughlin, et al., “Squamous cell
carcinoma of the penis and microscopic pathologic margins.Francisco E. Martins et al. 7
How much margin is needed for local cure?” Cancer, vol. 85,
pp. 299–300, 1999.
[26] B. Ubrig, M. Waldner, M. Fallahi, and S. Roth, “Preputial
ﬂap for primary closure after excision of tumors on the glans
penis,” Urology, vol. 58, no. 2, pp. 274–276, 2001.
[27] G.Gulino,F.Sasso,R.Falabella,andP.F.Bassi,“Distalurethral
reconstruction of the glans for penile carcinoma: results of a
noveltechniqueat1-yearoffollow-up,”TheJournalofUrology,
vol. 178, no. 3, pp. 941–944, 2007.
[28] M. Djordjevic, S. Perovic, and F. E. Martins, “Penile disas-
sembly for the conservative treatment of penile carcinoma,”
in preparation.
[29] S. Parkash, N. Ananthakrishnan, and P. Roy, “Refashioning of
phallusstumpsandphalloplastyinthetreatmentofcarcinoma
ofthepenis,”BritishJournalofSurgery,vol.73,no.11,pp.902–
905, 1986.
[30] O. N. Mazza and G. M. J. Cheliz, “Glanuloplasty with scrotal
ﬂap for partial penectomy,” The Journal of Urology, vol. 166,
no. 3, pp. 887–889, 2001.
[31] M. Djordjevic, S. Perovic, and G. Korac, “Penile carcinoma:
organ-sparing surgery,” Urology, vol. 68, supplement 1, p. 216,
2006, abstr. V-05.11.
[32] G. Venkov, “Organ-sparing surgery for invasive penile cancer
with use of buccal mucosal graft for resurfacing after excision
of tumors on the glans penis: early follow-up data,” Urology,
vol. 70, no. 3, supplement 1, p. 288, 2003, abstr. POS-03.52.
[33] M. L. Greenberger and B. A. Lowe, “Penile stump advance-
ment as an alternative to perineal urethrostomy after penile
amputation,” The Journal of Urology, vol. 161, no. 3, pp. 893–
894, 1999.
[34] E. Austoni, O. Fenice, Y. Kartalas Goumas, F. Colombo,
F. Mantovani, and E. Pisani, “New trends in the surgical
treatment of penile carcinoma,” Archivio Italiano di Urologia,
Andrologia, vol. 68, no. 3, pp. 163–168, 1996 (Italian).